Literature DB >> 12397729

Emergency surgery for patients with colorectal cancer over 90 years of age.

Fausto Catena1, Eddi Pasqualini, Valeria Tonini, Andrea Avanzolini, Orazio Campione.   

Abstract

BACKGROUND/AIMS: Colorectal cancer has an extremely poor prognosis in the elderly with high rates of emergency presentation and perioperative mortality. This report examines our experience and results in the emergency treatment of patients older than 90 years with colorectal cancer.
METHODOLOGY: From 1995 to 2000, 486 patients with colorectal cancer were operated on in an emergency surgery situation at the Department of Emergency Surgery of Sant'Orsola-Malpighi University Hospital. A retrospective analysis of 20 patients aged 90 or older was carried out.
RESULTS: Thirteen patients underwent resection of the primary growth and anastomosis and 7 subjects with carcinomatosis had palliative intervention by creating a stoma only or bypass anastomosis without resection. We registered two deaths caused by respiratory insufficiency and 2 postoperative complications successfully treated with medical therapy.
CONCLUSIONS: Emergency surgery for colorectal cancer in patients over 90 years of age can be performed safely without restrictions related to the age.

Entities:  

Mesh:

Year:  2002        PMID: 12397729

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Prognostic factors in 165 elderly colorectal cancer patients.

Authors:  Ke-Jun Nan; Hai-Xia Qin; Guang Yang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

Review 2.  Bowel obstruction: a narrative review for all physicians.

Authors:  Fausto Catena; Belinda De Simone; Federico Coccolini; Salomone Di Saverio; Massimo Sartelli; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2019-04-29       Impact factor: 5.469

3.  Emergency surgery for recurrent intraabdominal cancer.

Authors:  Fausto Catena; Filippo Gazzotti; Luca Ansaloni; Sonia Agrusti; Angelo De Cataldis; Luigi D'Alessandro; Mario Taffurelli
Journal:  World J Surg Oncol       Date:  2004-07-06       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.